| Terlipressin plus albumin is more effective than albumin alone in improving renal function in patients with cirrhosis and hepatorenal syndrome type 1 TD Boyer, AJ Sanyal, F Wong, RT Frederick, JR Lake, JG O’Leary, ... Gastroenterology 150 (7), 1579-1589. e2, 2016 | 320 | 2016 |
| Mechanism of indinavir-induced hyperbilirubinemia SD Zucker, X Qin, SD Rouster, F Yu, RM Green, P Keshavan, J Feinberg, ... Proceedings of the National Academy of Sciences 98 (22), 12671-12676, 2001 | 317 | 2001 |
| Serum bilirubin levels in the US population: gender effect and inverse correlation with colorectal cancer SD Zucker, PS Horn, KE Sherman Hepatology 40 (4), 827-835, 2004 | 291 | 2004 |
| Bilirubin inhibits iNOS expression and NO production in response to endotoxin in rats WW Wang, DLH Smith, SD Zucker Hepatology 40 (2), 424-433, 2004 | 248 | 2004 |
| Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration P Keshavan, TL Deem, SJ Schwemberger, GF Babcock, JM Cook-Mills, ... The journal of immunology 174 (6), 3709-3718, 2005 | 210 | 2005 |
| Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes SD Zucker, W Goessling, AG Hoppin Journal of Biological Chemistry 274 (16), 10852-10862, 1999 | 162 | 1999 |
| Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization P Keshavan, SJ Schwemberger, DLH Smith, GF Babcock, SD Zucker International journal of cancer 112 (3), 433-445, 2004 | 146 | 2004 |
| Hepatitis C transmission from seropositive, nonviremic donors to non–hepatitis C liver transplant recipients K Bari, K Luckett, T Kaiser, T Diwan, M Cuffy, MR Schoech, K Safdar, ... Hepatology 67 (5), 1673-1682, 2018 | 102 | 2018 |
| Hyperammonemic encephalopathy caused by carnitine deficiency BN Limketkai, SD Zucker Journal of general internal medicine 23, 210-213, 2008 | 86 | 2008 |
| Bilirubin prevents atherosclerotic lesion formation in low‐density lipoprotein receptor‐deficient mice by inhibiting endothelial VCAM‐1 and ICAM‐1 signaling ME Vogel, G Idelman, ES Konaniah, SD Zucker Journal of the American Heart Association 6 (4), e004820, 2017 | 84 | 2017 |
| Kinetics of Bilirubin Transfer between Serum Albumin and Membrane Vesicles: INSIGHT INTO THE MECHANISM OF ORGANIC ANION DELIVERY TO THE HEPATOCYTE PLASMA MEMBRANE (∗) SD Zucker, W Goessling, JL Gollan Journal of Biological Chemistry 270 (3), 1074-1081, 1995 | 79 | 1995 |
| Role of apolipoprotein D in the transport of bilirubin in plasma W Goessling, SD Zucker American Journal of Physiology-Gastrointestinal and Liver Physiology 279 (2 …, 2000 | 70 | 2000 |
| Bilirubin acts as an endogenous regulator of inflammation by disrupting adhesion molecule-mediated leukocyte migration ME Vogel, SD Zucker Inflammation and cell signaling 3 (1), 2016 | 68 | 2016 |
| Bilirubin inhibits the up-regulation of inducible nitric oxide synthase by scavenging reactive oxygen species generated by the toll-like receptor 4-dependent activation of … G Idelman, DLH Smith, SD Zucker Redox biology 5, 398-408, 2015 | 61 | 2015 |
| Anatomy and physiology of the liver R Saxena, SD Zucker, JM Crawford Hepatology 1, 3-30, 2003 | 55 | 2003 |
| Mechanism of the spontaneous transfer of unconjugated bilirubin between small unilamellar phosphatidylcholine vesicles SD Zucker, J Storch, ML Zeidel, JL Gollan Biochemistry 31 (12), 3184-3192, 1992 | 55 | 1992 |
| Membrane lipid composition and vesicle size modulate bilirubin intermembrane transfer. Evidence for membrane-directed trafficking of bilirubin in the hepatocyte. SD Zucker, W Goessling, ML Zeidel, JL Gollan Journal of Biological Chemistry 269 (30), 19262-19270, 1994 | 52 | 1994 |
| Bilirubin prevents acute DSS-induced colitis by inhibiting leukocyte infiltration and suppressing upregulation of inducible nitric oxide synthase SD Zucker, ME Vogel, TL Kindel, DLH Smith, G Idelman, U Avissar, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 309 (10 …, 2015 | 51 | 2015 |
| Liver function and prognosis, and influence of sacubitril/valsartan in patients with heart failure with reduced ejection fraction K Suzuki, B Claggett, M Minamisawa, M Packer, MR Zile, J Rouleau, ... European Journal of Heart Failure 22 (9), 1662-1671, 2020 | 49 | 2020 |
| Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease DLH Smith, NJ Shire, NB Watts, T Schmitter, G Szabo, SD Zucker Journal of Clinical Densitometry 9 (1), 105-113, 2006 | 47 | 2006 |
Wolfram GoesslingProfessor of Medicine, Harvard Medical School在 hms.harvard.edu 的电子邮件经过验证
